Safety Pharmacology Case Studies, Webinar On-Demand


You Won’t Want to Miss This Video!

Watch as, Dr. Michael R. Gralinski, CEO of CorDynamics, reviews the results of three GLP safety pharmacology validation studies.

The studies were conducted using telemetered dogs with well-characterized hemodynamic, electrocardiographic, and respiratory positive controls. All three studies demonstrated the ability to detect expected effects of positive controls with a high degree of reliability.

Watch video

The studies were conducted in Altasciences' purpose-built, isolated telemetry facility, with data review and interpretation by CorDynamics.

Speak with one of our experts today.

You may also be interested in: 
•    The Altascientist: Scientific Journal Issue 13 — Safety Pharmacology Studies, a Review
•    Fact Sheet: Safety Pharmacology
•    Webpage: Safety Pharmacology Overview and FAQs

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.